RITALIN-SR Drug Patent Profile
✉ Email this page to a colleague
When do Ritalin-sr patents expire, and what generic alternatives are available?
Ritalin-sr is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in RITALIN-SR is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ritalin-sr
A generic version of RITALIN-SR was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RITALIN-SR?
- What are the global sales for RITALIN-SR?
- What is Average Wholesale Price for RITALIN-SR?
Summary for RITALIN-SR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Clinical Trials: | 126 |
Patent Applications: | 3,514 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RITALIN-SR at DailyMed |
![RITALIN-SR drug patent expirations Drug patent expirations by year for RITALIN-SR](/p/graph/s/t/RITALIN-SR-patent-expirations.png)
Recent Clinical Trials for RITALIN-SR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins University | Phase 4 |
University of Florida | Early Phase 1 |
University of Zurich | Phase 1 |
US Patents and Regulatory Information for RITALIN-SR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | RITALIN-SR | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 018029-001 | Mar 30, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RITALIN-SR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | RITALIN-SR | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 018029-001 | Mar 30, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RITALIN-SR
See the table below for patents covering RITALIN-SR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 2736794 | ⤷ Sign Up | |
Japan | S5326318 | DOSAGE ONIT WITH CONTINUOUS PROPERTY | ⤷ Sign Up |
France | 2361915 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |